CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 200 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05939232
NCT05939232N/ARecruitingOn TrackUpdated 35mo ago
CompareCT.gov

Registry of X-linked Adrenoleukodystrophy

Beijing Tiantan Hospital·observational·Posted Jul 11, 2023·Updated Jul 11, 2023

In Brief

An observational study for X-linked Adrenoleukodystrophy. Currently recruiting, targeting 200 participants across 1 site.

Detailed Summary

This study is a observational study conducted through recruiting X-linked adrenoleukodystrophy (X-ALD) patients, to build a comprehensive evaluation and long-term follow-up platform for X-ALD patients, and to provide a theoretical basis for the treatment and management of X-ALD patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsX-linked Adrenoleukodystrophy
CountriesChina
Collaborators--

Timeline

N/ARecruiting
202420252026202720282029
First PostedJul 11, 2023
Enrollment StartJul 20, 2023
Primary CompletionDec 1, 2028
TodayJul 1, 2026
Enrollment to primary: 5.4 yearsPosted 3.0 years agoPrimary completion in 2.4 years